Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001698082-25-000003
Filing Date
2025-10-15
Accepted
2025-10-15 16:10:06
Documents
1
Period of Report
2025-10-10

Document Format Files

Seq Description Document Type Size
1 form4-10152025_041001.html 4  
1 form4-10152025_041001.xml 4 4943
  Complete submission text file 0001698082-25-000003.txt   6536
Mailing Address 7 BRYANT PARK 23RD FLOOR NEW YORK CITY NY 10018
Business Address 650-475-3734
Shah Nimish P (Reporting) CIK: 0001698082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41740 | Film No.: 251394934

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Issuer) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)